TCL Archive In Brief: Cancer Program A “Noble Venture,” Kennedy Says; $937 Million Not Enough, Upton Says April 13, 1979
TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014
TCL Archive In Brief: Reauthorization May Be Wrapped Up This Week As House, Senate Work Toward Compromise October 14, 1988